Table 1 Baseline demographic and clinical characteristics of subjects
Total (n = 1122) | Men (n = 427) | Women (n = 695) | p | |
|---|---|---|---|---|
Age (years) | 55.0 (0.4) | 57.6 (0.5) | 53.4 (0.4) | <0.001 |
Smoking status. n (%) | ||||
Yes | 224 (20.0) | 79 (18.6) | 144 (21.4) | <0.001 |
No or past | 898 (80.0) | 352 (81.4) | 546 (78.6) | |
Alcohol status. n (%) | ||||
Yes | 710 (63.2) | 314 (73.5) | 396 (57.0) | <0.001 |
No or past | 412 (36.8) | 113 (26.5) | 299 (43.0) | |
Weight (kg) | 72.4 (0.4) | 81.0 (0.5) | 67.0 (0.4) | <0.001 |
Height (cm) | 163.3 (0.2) | 170.8 (0.3) | 158.6 (0.2) | <0.001 |
Body mass index (kg/m2) | 26.8 (24.1-29.8) | 27.4 (25.6-30.1) | 26.0 (22.9-29.5) | 0.001 |
Waist circumference (cm) | 92.0 (85.0-100.0) | 97.0 (92.0-104.0) | 88.0 (81.0-96.0) | <0.001 |
Triglycerides (mg/dL) | 95.0 (71.0-131.0) | 107.0 (80.5-152.2) | 87.0 (66.0-121.0) | <0.001 |
HDL-cholesterol (mg/dL) | 58.0 (48.0-68.0) | 50.0 (43.0-59.0) | 62.0 (53.0-72.0) | <0.001 |
TG/HDL-C (mg/dL) | 1.6 (1.1-2.5) | 2.0 (1.4-3.4) | 1.4 (1.0-2.2) | <0.001 |
HOMA-IR | 1.4 (0.8-2.2) | 1.7 (0.9-2.5) | 1.3 (0.8-2.1) | 0.005 |
Lipid-lowering drugs, n (%) | 187 (16.7) | 98 (23.0) | 89 (12.8) | <0.001 |
Office systolic blood pressure (mmHg) | 125 (0.6) | 130 (0.7) | 121 (0.5) | <0.001 |
Office diastolic blood pressure (mmHg) | 77 (0.3) | 78 (0.4) | 75.8 (0.3) | <0.001 |
Mean arterial blood pressure (mmHg) | 91 (0.4) | 96 (0.4) | 88 (0.4) | <0.001 |
Antihypertensive drugs, n (%) | 322 (28.7) | 261 (61.1) | 156 (22.4) | <0.001 |
Time accelerometer worn, min/day | 931.2 (9.5) | 941.6 (11.2) | 924.8 (8.0) | 0.239 |
Used valid days, n | 5.5 (0.1) | 5.4 (0.1) | 5.6 (0.1) | 0.994 |
MVPA, min/day | 46.5 (1.1) | 53.8 (1.5) | 42.0 (0.9) | <0.001 |
Meet recommendations for MVPAa. n (%) | 582 (51.9) | 224 (52.4) | 355 (51.1) | 0.003 |
Sedentary time, min/day | 580.3 (7.8) | 601.7 (9.0) | 567.2 (6.3) | 0.003 |